Ophthalmic Lasers

Ophthalmic Lasers

Global Ophthalmic Lasers Market to Reach US$2.0 Billion by 2030

The global market for Ophthalmic Lasers estimated at US$1.4 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of the analysis period. Growth in the Excimer Lasers segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$378.6 Million While China is Forecast to Grow at 7.8% CAGR

The Ophthalmic Lasers market in the U.S. is estimated at US$378.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$458.7 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Ophthalmic Lasers Market - Key Trends & Drivers Summarized

Ophthalmic lasers are specialized medical devices used in the field of ophthalmology for the treatment and diagnosis of various eye conditions. These lasers operate by emitting a focused beam of light, allowing for precise and minimally invasive procedures on delicate ocular tissues. The use of lasers in ophthalmology spans a wide range of applications including retinal surgery, cataract removal, glaucoma treatment, and refractive surgery such as LASIK. Different types of lasers, such as excimer, femtosecond, and Nd, are employed based on the specific medical need. For instance, excimer lasers are commonly used in corrective eye surgeries due to their ability to reshape the cornea with high precision, while Nd lasers are often utilized for posterior capsulotomy after cataract surgery. The precision and efficacy of these devices have revolutionized ophthalmic treatments, making them an indispensable tool in modern eye care.

The technological advancements in ophthalmic lasers have significantly enhanced their capabilities, leading to improved patient outcomes and expanded therapeutic options. Innovations such as the development of femtosecond lasers have allowed for bladeless cataract surgeries and more precise corneal incisions, reducing recovery times and improving surgical accuracy. Additionally, advancements in laser imaging and guidance systems have increased the safety and efficacy of laser treatments, enabling real-time monitoring and adjustments during procedures. These technologies have also broadened the range of treatable conditions, from complex retinal disorders to minimally invasive glaucoma surgeries. The integration of computer-assisted systems and artificial intelligence in laser devices further augments their precision and adaptability, offering personalized treatment plans and reducing the risk of complications. As a result, ophthalmic lasers continue to be at the forefront of innovation in eye care, continually evolving to meet the demands of modern medicine.

The growth in the ophthalmic lasers market is driven by several factors. The increasing prevalence of eye disorders such as cataracts, glaucoma, and diabetic retinopathy is a significant driver, as these conditions often require laser-based interventions. Additionally, the aging global population contributes to a higher demand for ophthalmic treatments, as the incidence of age-related eye diseases rises. Technological advancements in laser systems, including the development of portable and user-friendly devices, have made these treatments more accessible to a broader range of healthcare providers and patients. The rising adoption of minimally invasive surgeries also fuels market growth, as patients seek procedures with shorter recovery times and lower risk of complications. Furthermore, increasing healthcare expenditure and better reimbursement policies for ophthalmic procedures in various regions enhance the affordability and adoption of laser treatments. Consumer behavior trends, such as the growing awareness and acceptance of laser eye surgeries for vision correction, further stimulate market demand. Collectively, these factors create a robust growth trajectory for the ophthalmic lasers market, promising continued advancements and widespread adoption in the coming years.

Select Competitors (Total 32 Featured) -

• Johnson & Johnson Services, Inc.
• Bausch & Lomb, Inc.
• Lumenis Ltd.
• Carl Zeiss Meditec AG
• Johnson & Johnson Vision Care, Inc.
• A.R.C. Laser GmbH
• IMRA America, Inc.
• LENSAR, Inc.
• Menlo Systems GmbH
• Lumibird Group
• Bausch Health Companies Inc.
• KMLabs, Inc.
• ASICO LLC
• LCA-Vision, Inc. (LasikPlus)
• Korea Electrotechnology Research Institute (KERI)

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.